Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China
· Delayed Price · Currency is CNY 16.03
-0.03 (-0.19%)
Apr 30, 2026, 1:45 PM CST
Cabio Biotech (Wuhan) Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,679 | 3,883 | 3,203 | 3,013 | 5,438 | 7,373 | Upgrade
|
| Market Cap Growth | -35.95% | 21.24% | 6.31% | -44.60% | -26.24% | 55.15% | Upgrade
|
| Enterprise Value | 2,507 | 3,741 | 3,077 | 2,760 | 4,910 | 6,676 | Upgrade
|
| Last Close Price | 16.06 | 23.28 | 18.88 | 17.49 | 31.30 | 42.04 | Upgrade
|
| PE Ratio | 48.72 | 27.02 | 25.79 | 32.97 | 84.48 | 57.34 | Upgrade
|
| Forward PE | - | 19.04 | 22.89 | 23.21 | - | - | Upgrade
|
| PS Ratio | 6.41 | 6.90 | 5.77 | 6.79 | 12.55 | 21.00 | Upgrade
|
| PB Ratio | 1.68 | 2.36 | 2.04 | 2.02 | 3.82 | 5.34 | Upgrade
|
| P/TBV Ratio | 1.73 | 2.44 | 2.12 | 2.10 | 3.93 | 5.39 | Upgrade
|
| P/FCF Ratio | 27.58 | 30.93 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 11.94 | 14.38 | 18.51 | 43.73 | 30.83 | 71.38 | Upgrade
|
| PEG Ratio | - | 0.75 | 0.75 | 0.75 | - | - | Upgrade
|
| EV/Sales Ratio | 5.99 | 6.64 | 5.54 | 6.22 | 11.33 | 19.02 | Upgrade
|
| EV/EBITDA Ratio | 19.77 | 17.41 | 19.57 | 22.42 | 54.31 | 53.40 | Upgrade
|
| EV/EBIT Ratio | 39.92 | 24.40 | 29.89 | 36.28 | 76.29 | 65.65 | Upgrade
|
| EV/FCF Ratio | 25.81 | 29.80 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.05 | 0.01 | 0.01 | 0.02 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 1.63 | 0.39 | 0.12 | 0.10 | 0.36 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 2.13 | 0.66 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.11 | -0.12 | -0.08 | -0.15 | -0.35 | -0.49 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.43 | -0.91 | -0.85 | -1.84 | -5.47 | -5.39 | Upgrade
|
| Net Debt / FCF Ratio | -1.85 | -1.55 | 3.47 | 0.99 | 6.76 | 9.60 | Upgrade
|
| Asset Turnover | 0.23 | 0.32 | 0.34 | 0.28 | 0.28 | 0.25 | Upgrade
|
| Inventory Turnover | 1.35 | 1.88 | 2.60 | 2.73 | 3.29 | 2.46 | Upgrade
|
| Quick Ratio | 2.57 | 3.07 | 4.67 | 4.77 | 4.35 | 14.93 | Upgrade
|
| Current Ratio | 3.76 | 4.44 | 6.45 | 6.31 | 5.03 | 16.59 | Upgrade
|
| Return on Equity (ROE) | 3.11% | 8.67% | 7.84% | 5.92% | 4.39% | 9.71% | Upgrade
|
| Return on Assets (ROA) | 2.15% | 5.40% | 3.90% | 2.95% | 2.63% | 4.49% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.33% | 9.13% | 6.55% | 5.98% | 6.19% | 14.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.70% | 9.00% | 6.50% | 5.10% | 4.50% | 7.30% | Upgrade
|
| Earnings Yield | 2.06% | 3.70% | 3.88% | 3.03% | 1.18% | 1.74% | Upgrade
|
| FCF Yield | 3.63% | 3.23% | -1.20% | -7.59% | -1.34% | -0.95% | Upgrade
|
| Dividend Yield | 1.27% | - | 1.06% | 1.14% | 0.69% | 0.56% | Upgrade
|
| Payout Ratio | 66.24% | 24.95% | 27.38% | 40.04% | 61.90% | 31.01% | Upgrade
|
| Buyback Yield / Dilution | -0.75% | 0.44% | 0.80% | 0.11% | -0.69% | -0.31% | Upgrade
|
| Total Shareholder Return | 0.55% | 0.44% | 1.87% | 1.26% | -0.01% | 0.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.